Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

被引：0
|
作者：
Bodo Haas
Veronika Klinger
Christina Keksel
Verena Bonigut
Daniela Kiefer
Julia Caspers
Julia Walther
Maria Wos-Maganga
Sandra Weickhardt
Gabriele Röhn
Marco Timmer
Roland Frötschl
Niels Eckstein
机构：
[1] Federal Institute for Drugs and Medical Devices,Institute of Pharmacy
[2] University of Bonn,Applied Pharmacy
[3] University of Applied Sciences Kaiserslautern,Faculty of Applied Natural Sciences
[4] Cologne University of Applied Sciences,Department of General Neurosurgery, Center for Neurosurgery
[5] University Hospital Cologne,undefined
来源：
Cancer Cell International | / 18卷
关键词：
Glioblastoma; Drug resistance; PI3K; Temozolomide; Cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
    Haas, Bodo
    Klinger, Veronika
    Keksel, Christina
    Bonigut, Verena
    Kiefer, Daniela
    Caspers, Julia
    Walther, Julia
    Wos-Maganga, Maria
    Weickhardt, Sandra
    Roehn, Gabriele
    Timmer, Marco
    Froetschl, Roland
    Eckstein, Niels
    CANCER CELL INTERNATIONAL, 2018, 18
  • [2] Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
    Du, Wei
    Pang, Changhe
    Xue, Yake
    Zhang, Qingjun
    Wei, Xinting
    ONCOLOGY LETTERS, 2015, 10 (05) : 3266 - 3270
  • [3] A PI3K inhibitor-induced growth inhibition of cancer cells is linked to MEK-ERK pathway
    Duff, Angela
    Kavege, Llona
    Baquier, Jocelyn
    Hu, Tang
    ANTI-CANCER DRUGS, 2021, 32 (05) : 517 - 525
  • [4] DEPLETION OF CLK2 SENSITIZES GLIOMA CELLS TO PI3K/mTOR AND FGFR INHIBITION
    Park, Soon Young
    Dong, Jianwen
    Martinez-Ledesma, Emmanuel
    Piao, Yuji
    Verhaak, Roel G. W.
    de Groot, John F.
    NEURO-ONCOLOGY, 2016, 18 : 44 - 44
  • [5] Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells
    Wu, Y. Linda
    Maachani, Uday Bhanu
    Schweitzer, Melanie
    Singh, Ranjodh
    Wang, Melinda
    Chang, Raymond
    Souweidane, Mark M.
    TRANSLATIONAL ONCOLOGY, 2017, 10 (02): : 221 - 228
  • [6] Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells
    Roy, Bibhas
    Pattanaik, Amp K.
    Das, Joyjyoti
    Bhutia, Sujit K.
    Behera, Birendra
    Singh, Prashant
    Maiti, Tapas K.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2014, 210 : 96 - 102
  • [7] Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
    Rittler, Dominika
    Molnar, Eszter
    Baranyi, Marcell
    Garay, Tamas
    Hegedus, Luca
    Aigner, Clemens
    Tovari, Jozsef
    Timar, Jozsef
    Hegedus, Balazs
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 18
  • [8] Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma
    Guenther, Monika Katharina
    Graab, Ulrike
    Fulda, Simone
    CANCER LETTERS, 2013, 337 (02) : 200 - 209
  • [9] Inhibition of PI3K-AKT-mTOR but not of RAF-MEK-ERK signaling sensitizes melanoma cells to chemotherapy
    Niessner, H.
    Sinnberg, T.
    Lasithiotakis, K.
    Schittek, B.
    Kulms, D.
    Maczey, E.
    Gogel, J.
    Garbe, C.
    Meier, F.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 300 - 300
  • [10] Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway
    Zheng, Yuan-ting
    Yang, Hui-ying
    Li, Tao
    Zhao, Bei
    Shao, Teng-fei
    Xiang, Xiao-qiang
    Cai, Wei-min
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (05) : 614 - 626
12345